Insulet
PODD
#1256
Rank
A$25.85 B
Marketcap
A$367.34
Share price
0.27%
Change (1 day)
-18.92%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): A$0.56 Billion

According to Insulet's latest financial reports the company's current earnings are A$2.52 Billion. In 2024 the company made an earning of A$0.49 Billion, an increase over its 2023 earnings that were of A$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.56 B15.13%
2024 A$0.49 B36.76%
2023 A$0.36 B481.9%
2022 A$61.89 M-45.24%
2021 A$0.11 B43.35%
2020 A$78.83 M18.51%
2019 A$66.52 M41.16%
2018 A$47.12 M-711.95%
2017 -A$7.71 Million-56.85%
2016 -A$17.85 Million-79.31%
2015 -A$86.29 Million63.85%
2014 -A$52.66 Million31.04%
2013 -A$40.19 Million-21.96%
2012 -A$51.5 Million
2010 -A$49.12 Million-42.38%
2009 -A$85.24 Million-33.56%
2008 -A$0.13 Billion65.93%
2007 -A$77.32 Million209.75%
2006 -A$24.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.52 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.68 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$9.20 B 1,662.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$32.31 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.3 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
A$0.17 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.40 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA